Jeffrey S Wefel
Jeffrey S Wefel
Dirección de correo verificada de mdanderson.org
TítuloCitado porAño
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
EL Chang, JS Wefel, KR Hess, PK Allen, FF Lang, DG Kornguth, ...
The lancet oncology 10 (11), 1037-1044, 2009
16302009
A randomized trial of bevacizumab for newly diagnosed glioblastoma
MR Gilbert, JJ Dignam, TS Armstrong, JS Wefel, DT Blumenthal, ...
New England Journal of Medicine 370 (8), 699-708, 2014
16252014
The cognitive sequelae of standard‐dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial
JS Wefel, R Lenzi, RL Theriault, RN Davis, CA Meyers
Cancer: Interdisciplinary International Journal of the American Cancer …, 2004
6332004
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial
MR Gilbert, M Wang, KD Aldape, R Stupp, ME Hegi, KA Jaeckle, ...
Journal of clinical oncology 31 (32), 4085, 2013
5312013
International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer
JS Wefel, J Vardy, T Ahles, SB Schagen
The lancet oncology 12 (7), 703-708, 2011
4752011
Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system
VA Levin, L Bidaut, P Hou, AJ Kumar, JS Wefel, BN Bekele, S Prabhu, ...
International Journal of Radiation Oncology* Biology* Physics 79 (5), 1487-1495, 2011
4552011
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial
PD Brown, S Pugh, NN Laack, JS Wefel, D Khuntia, C Meyers, A Choucair, ...
Neuro-oncology 15 (10), 1429-1437, 2013
4412013
Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer
JS Wefel, AK Saleeba, AU Buzdar, CA Meyers
Cancer 116 (14), 3348-3356, 2010
3932010
Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non–small-cell lung cancer
JW Welsh, R Komaki, A Amini, MF Munsell, W Unger, PK Allen, JY Chang, ...
Journal of clinical oncology 31 (7), 895, 2013
3922013
Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop
J Vardy, JS Wefel, T Ahles, IF Tannock, SB Schagen
Annals of Oncology 19 (4), 623-629, 2008
3482008
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
MJ van den Bent, JS Wefel, D Schiff, MJB Taphoorn, K Jaeckle, L Junck, ...
The lancet oncology 12 (6), 583-593, 2011
3412011
‘Chemobrain’in breast carcinoma? A prologue
JS Wefel, R Lenzi, R Theriault, AU Buzdar, S Cruickshank, CA Meyers
Cancer: Interdisciplinary International Journal of the American Cancer …, 2004
3392004
Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy
J Dietrich, M Monje, J Wefel, C Meyers
Oncologist 13 (12), 1285, 2008
2912008
Chemotherapy-related cognitive dysfunction
JS Wefel, SB Schagen
Current neurology and neuroscience reports 12 (3), 267-275, 2012
2672012
The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity
CA Meyers, JS Wefel
Journal of Clinical Oncology 21 (19), 3557-3558, 2003
1972003
Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer‐related cognitive impairment in adults
JS Wefel, SR Kesler, KR Noll, SB Schagen
CA: a cancer journal for clinicians 65 (2), 123-138, 2015
1922015
Memory performance after head injury: Contributions of malingering, litigation status, psychological factors, and medication use
J Suhr, D Tranel, J Wefel, J Barrash
Journal of clinical and experimental neuropsychology 19 (4), 500-514, 1997
1691997
Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target
JS Wefel, AE Kayl, CA Meyers
British Journal of Cancer 90 (9), 1691-1696, 2004
1592004
Neuropsychological sequelae of non-central nervous system cancer and cancer therapy
JS Wefel, ME Witgert, CA Meyers
Neuropsychology review 18 (2), 121-131, 2008
1382008
RTOG 0525: A randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose-dense (dd) schedule in newly diagnosed glioblastoma (GBM).
MR Gilbert, M Wang, KD Aldape, R Stupp, M Hegi, KA Jaeckle, ...
Journal of Clinical Oncology 29 (15_suppl), 2006-2006, 2011
1342011
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20